Coronavirus (COVID-19): visiting The Royal Marsden suspended

Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.

Meet the Team

We are a highly experienced team of dedicated clinical and research scientists offering extensive genomic testing specific to oncology.  

The team consists of, Associate Practitioners, Medical Technical Officers, Genetic Technologists, Clinical scientists, Consultant Clinical Scientists and Research Scientists working alongside each other to provide a fully comprehensive Clinical Genomics Service. 

Our scientific expertise allows us to deliver cutting-edge genomic technology and provide the interpretation of complex genomic data to inform personalised treatment plans for patients, improving their quality of care.  We pride ourselves in collaborative working between our Scientists and Clinicians promoting clinical innovation for cancer patients. 

For NHS enquiries please contact:

Julie Howard-Reeves, Operational Lead 020 8722 4232 Julie.Howard-Reeves@icr.ac.uk

Mikel Valganon, Deputy Operational Lead 020 8915 6543 Mikel.ValganonPetrizan@rmh.nhs.uk

For Private Patient enquiries please contact:

Dr Lisa Thompson, Head of Commercial Development 020 8915 6565 Lisa.Thompson@rmh.nhs.uk

For Commercial enquiries please contact:

Dr Lisa Thompson, Head of Commercial Development 020 8915 6565 Lisa.Thompson@rmh.nhs.uk,

Dr Michael Hubank, Scientific Director Michael.Hubank@icr.ac.uk 

Andrew Feber: Deputy Scientific Director (Clinical Genomics)  Andrew.Feber@icr.ac.uk

Alison Morilla, Head of Transformation & Clinical Programmes, Alison.Morilla2@rmh.nhs.uk